Loading…
Antiretroviral drug toxicity in human immunodeficiency virus infected children
Paediatric Human Immunodeficiency Virus infection (HIV) nowadays is a chronic disease with an excellent long term prognosis, but lifelong combined antiretroviral treatment is required. However, an improved quality of life in this population is limited by adverse drug effects. The highest risk of tre...
Saved in:
Published in: | Anales de pediatría (Barcelona, Spain : 2003) Spain : 2003), 2008-05, Vol.68 (5), p.425 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | Spanish |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 5 |
container_start_page | 425 |
container_title | Anales de pediatría (Barcelona, Spain : 2003) |
container_volume | 68 |
creator | Núñez Cuadros, E Mellado Peña, M J Rivera Cuello, M Penim Fernández, M Piñeiro Pérez, R García-Hortelano, M Cilleruelo Ortega, M J Villota Arrieta, J Martín-Fontelos, P |
description | Paediatric Human Immunodeficiency Virus infection (HIV) nowadays is a chronic disease with an excellent long term prognosis, but lifelong combined antiretroviral treatment is required. However, an improved quality of life in this population is limited by adverse drug effects. The highest risk of treatment toxicity is developing a complete metabolic syndrome including: Hyperlipemia, lipodystrophy, insulin resistance, lactic acidosis, osteopenia, hypertension, and specific system and organ toxicity, such as the kidney, liver, CNS or bone marrow. The risk of cardiovascular disease adult life and also definitive bone mass damage are the most significant metabolic costs that have to paid for increased survival. Most of these toxicities were able to be adequately treated but, pharmacological interferences, patient intolerance and the high number of drugs are the problems that limit the adherence to treatment, which is essential for a good therapeutical efficacy. In this article, we present four HIV paediatric patients who presented with almost the whole range of metabolic toxicities, and a practical overview of therapeutical management. |
format | article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_18447985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18447985</sourcerecordid><originalsourceid>FETCH-LOGICAL-p545-5e2c7f4b6118c767456ce86565e85f8dc4996b4ec16c74a715bd6ba03ae2d6773</originalsourceid><addsrcrecordid>eNo1j8tKxDAYhbNQnHH0FSQvUGja5E-6HAZvMOhm9kMuf5xIk5a0Efv2FtTVgfMdPjhXZMugExWv23ZDbqfps64bBY28IRumOJedElvytk9zyDjn4Stk3VOXywedh-9gw7zQkOilRJ1oiLGkwaFfe0x2oeu6TCv3aGd01F5C7zKmO3LtdT_h_V_uyOnp8XR4qY7vz6-H_bEaBReVwMZKzw0wpqwEyQVYVCBAoBJeOcu7DgxHy8BKriUTxoHRdauxcSBluyMPv9qxmIjuPOYQdV7O_7_aH4geSjM</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Antiretroviral drug toxicity in human immunodeficiency virus infected children</title><source>ScienceDirect</source><creator>Núñez Cuadros, E ; Mellado Peña, M J ; Rivera Cuello, M ; Penim Fernández, M ; Piñeiro Pérez, R ; García-Hortelano, M ; Cilleruelo Ortega, M J ; Villota Arrieta, J ; Martín-Fontelos, P</creator><creatorcontrib>Núñez Cuadros, E ; Mellado Peña, M J ; Rivera Cuello, M ; Penim Fernández, M ; Piñeiro Pérez, R ; García-Hortelano, M ; Cilleruelo Ortega, M J ; Villota Arrieta, J ; Martín-Fontelos, P</creatorcontrib><description>Paediatric Human Immunodeficiency Virus infection (HIV) nowadays is a chronic disease with an excellent long term prognosis, but lifelong combined antiretroviral treatment is required. However, an improved quality of life in this population is limited by adverse drug effects. The highest risk of treatment toxicity is developing a complete metabolic syndrome including: Hyperlipemia, lipodystrophy, insulin resistance, lactic acidosis, osteopenia, hypertension, and specific system and organ toxicity, such as the kidney, liver, CNS or bone marrow. The risk of cardiovascular disease adult life and also definitive bone mass damage are the most significant metabolic costs that have to paid for increased survival. Most of these toxicities were able to be adequately treated but, pharmacological interferences, patient intolerance and the high number of drugs are the problems that limit the adherence to treatment, which is essential for a good therapeutical efficacy. In this article, we present four HIV paediatric patients who presented with almost the whole range of metabolic toxicities, and a practical overview of therapeutical management.</description><identifier>ISSN: 1695-4033</identifier><identifier>PMID: 18447985</identifier><language>spa</language><publisher>Spain</publisher><subject>Acidosis, Lactic - chemically induced ; Adolescent ; Anti-Retroviral Agents - adverse effects ; Bone Diseases, Metabolic - chemically induced ; Bone Diseases, Metabolic - diagnostic imaging ; Child ; Child, Preschool ; Female ; HIV Infections - drug therapy ; Humans ; Hyperlipidemias - chemically induced ; Hypertension - chemically induced ; Insulin Resistance ; Lipodystrophy - chemically induced ; Metabolic Syndrome - chemically induced ; Radiography ; Zidovudine - adverse effects</subject><ispartof>Anales de pediatría (Barcelona, Spain : 2003), 2008-05, Vol.68 (5), p.425</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18447985$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Núñez Cuadros, E</creatorcontrib><creatorcontrib>Mellado Peña, M J</creatorcontrib><creatorcontrib>Rivera Cuello, M</creatorcontrib><creatorcontrib>Penim Fernández, M</creatorcontrib><creatorcontrib>Piñeiro Pérez, R</creatorcontrib><creatorcontrib>García-Hortelano, M</creatorcontrib><creatorcontrib>Cilleruelo Ortega, M J</creatorcontrib><creatorcontrib>Villota Arrieta, J</creatorcontrib><creatorcontrib>Martín-Fontelos, P</creatorcontrib><title>Antiretroviral drug toxicity in human immunodeficiency virus infected children</title><title>Anales de pediatría (Barcelona, Spain : 2003)</title><addtitle>An Pediatr (Barc)</addtitle><description>Paediatric Human Immunodeficiency Virus infection (HIV) nowadays is a chronic disease with an excellent long term prognosis, but lifelong combined antiretroviral treatment is required. However, an improved quality of life in this population is limited by adverse drug effects. The highest risk of treatment toxicity is developing a complete metabolic syndrome including: Hyperlipemia, lipodystrophy, insulin resistance, lactic acidosis, osteopenia, hypertension, and specific system and organ toxicity, such as the kidney, liver, CNS or bone marrow. The risk of cardiovascular disease adult life and also definitive bone mass damage are the most significant metabolic costs that have to paid for increased survival. Most of these toxicities were able to be adequately treated but, pharmacological interferences, patient intolerance and the high number of drugs are the problems that limit the adherence to treatment, which is essential for a good therapeutical efficacy. In this article, we present four HIV paediatric patients who presented with almost the whole range of metabolic toxicities, and a practical overview of therapeutical management.</description><subject>Acidosis, Lactic - chemically induced</subject><subject>Adolescent</subject><subject>Anti-Retroviral Agents - adverse effects</subject><subject>Bone Diseases, Metabolic - chemically induced</subject><subject>Bone Diseases, Metabolic - diagnostic imaging</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>HIV Infections - drug therapy</subject><subject>Humans</subject><subject>Hyperlipidemias - chemically induced</subject><subject>Hypertension - chemically induced</subject><subject>Insulin Resistance</subject><subject>Lipodystrophy - chemically induced</subject><subject>Metabolic Syndrome - chemically induced</subject><subject>Radiography</subject><subject>Zidovudine - adverse effects</subject><issn>1695-4033</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNo1j8tKxDAYhbNQnHH0FSQvUGja5E-6HAZvMOhm9kMuf5xIk5a0Efv2FtTVgfMdPjhXZMugExWv23ZDbqfps64bBY28IRumOJedElvytk9zyDjn4Stk3VOXywedh-9gw7zQkOilRJ1oiLGkwaFfe0x2oeu6TCv3aGd01F5C7zKmO3LtdT_h_V_uyOnp8XR4qY7vz6-H_bEaBReVwMZKzw0wpqwEyQVYVCBAoBJeOcu7DgxHy8BKriUTxoHRdauxcSBluyMPv9qxmIjuPOYQdV7O_7_aH4geSjM</recordid><startdate>200805</startdate><enddate>200805</enddate><creator>Núñez Cuadros, E</creator><creator>Mellado Peña, M J</creator><creator>Rivera Cuello, M</creator><creator>Penim Fernández, M</creator><creator>Piñeiro Pérez, R</creator><creator>García-Hortelano, M</creator><creator>Cilleruelo Ortega, M J</creator><creator>Villota Arrieta, J</creator><creator>Martín-Fontelos, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200805</creationdate><title>Antiretroviral drug toxicity in human immunodeficiency virus infected children</title><author>Núñez Cuadros, E ; Mellado Peña, M J ; Rivera Cuello, M ; Penim Fernández, M ; Piñeiro Pérez, R ; García-Hortelano, M ; Cilleruelo Ortega, M J ; Villota Arrieta, J ; Martín-Fontelos, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p545-5e2c7f4b6118c767456ce86565e85f8dc4996b4ec16c74a715bd6ba03ae2d6773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2008</creationdate><topic>Acidosis, Lactic - chemically induced</topic><topic>Adolescent</topic><topic>Anti-Retroviral Agents - adverse effects</topic><topic>Bone Diseases, Metabolic - chemically induced</topic><topic>Bone Diseases, Metabolic - diagnostic imaging</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>HIV Infections - drug therapy</topic><topic>Humans</topic><topic>Hyperlipidemias - chemically induced</topic><topic>Hypertension - chemically induced</topic><topic>Insulin Resistance</topic><topic>Lipodystrophy - chemically induced</topic><topic>Metabolic Syndrome - chemically induced</topic><topic>Radiography</topic><topic>Zidovudine - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Núñez Cuadros, E</creatorcontrib><creatorcontrib>Mellado Peña, M J</creatorcontrib><creatorcontrib>Rivera Cuello, M</creatorcontrib><creatorcontrib>Penim Fernández, M</creatorcontrib><creatorcontrib>Piñeiro Pérez, R</creatorcontrib><creatorcontrib>García-Hortelano, M</creatorcontrib><creatorcontrib>Cilleruelo Ortega, M J</creatorcontrib><creatorcontrib>Villota Arrieta, J</creatorcontrib><creatorcontrib>Martín-Fontelos, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Anales de pediatría (Barcelona, Spain : 2003)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Núñez Cuadros, E</au><au>Mellado Peña, M J</au><au>Rivera Cuello, M</au><au>Penim Fernández, M</au><au>Piñeiro Pérez, R</au><au>García-Hortelano, M</au><au>Cilleruelo Ortega, M J</au><au>Villota Arrieta, J</au><au>Martín-Fontelos, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antiretroviral drug toxicity in human immunodeficiency virus infected children</atitle><jtitle>Anales de pediatría (Barcelona, Spain : 2003)</jtitle><addtitle>An Pediatr (Barc)</addtitle><date>2008-05</date><risdate>2008</risdate><volume>68</volume><issue>5</issue><spage>425</spage><pages>425-</pages><issn>1695-4033</issn><abstract>Paediatric Human Immunodeficiency Virus infection (HIV) nowadays is a chronic disease with an excellent long term prognosis, but lifelong combined antiretroviral treatment is required. However, an improved quality of life in this population is limited by adverse drug effects. The highest risk of treatment toxicity is developing a complete metabolic syndrome including: Hyperlipemia, lipodystrophy, insulin resistance, lactic acidosis, osteopenia, hypertension, and specific system and organ toxicity, such as the kidney, liver, CNS or bone marrow. The risk of cardiovascular disease adult life and also definitive bone mass damage are the most significant metabolic costs that have to paid for increased survival. Most of these toxicities were able to be adequately treated but, pharmacological interferences, patient intolerance and the high number of drugs are the problems that limit the adherence to treatment, which is essential for a good therapeutical efficacy. In this article, we present four HIV paediatric patients who presented with almost the whole range of metabolic toxicities, and a practical overview of therapeutical management.</abstract><cop>Spain</cop><pmid>18447985</pmid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1695-4033 |
ispartof | Anales de pediatría (Barcelona, Spain : 2003), 2008-05, Vol.68 (5), p.425 |
issn | 1695-4033 |
language | spa |
recordid | cdi_pubmed_primary_18447985 |
source | ScienceDirect |
subjects | Acidosis, Lactic - chemically induced Adolescent Anti-Retroviral Agents - adverse effects Bone Diseases, Metabolic - chemically induced Bone Diseases, Metabolic - diagnostic imaging Child Child, Preschool Female HIV Infections - drug therapy Humans Hyperlipidemias - chemically induced Hypertension - chemically induced Insulin Resistance Lipodystrophy - chemically induced Metabolic Syndrome - chemically induced Radiography Zidovudine - adverse effects |
title | Antiretroviral drug toxicity in human immunodeficiency virus infected children |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A18%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antiretroviral%20drug%20toxicity%20in%20human%20immunodeficiency%20virus%20infected%20children&rft.jtitle=Anales%20de%20pediatr%C3%ADa%20(Barcelona,%20Spain%20:%202003)&rft.au=N%C3%BA%C3%B1ez%20Cuadros,%20E&rft.date=2008-05&rft.volume=68&rft.issue=5&rft.spage=425&rft.pages=425-&rft.issn=1695-4033&rft_id=info:doi/&rft_dat=%3Cpubmed%3E18447985%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p545-5e2c7f4b6118c767456ce86565e85f8dc4996b4ec16c74a715bd6ba03ae2d6773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18447985&rfr_iscdi=true |